At Commercial Eyes, we are dedicated to staying at the forefront of the pharmaceutical and healthcare industry by developing innovative tools and frameworks that provide valuable insights for our clients.
Our latest achievement in this pursuit is the creation of TRoVE (TRansfer of ValuE), a transformative database that elevates the utility of Medicines Australia (MA) Transparency Reports.
Bridging the Gap: The Genesis of TRoVE
MA Transparency Reports play a crucial role in promoting transparency between healthcare professionals (HCPs) and pharmaceutical companies. In examining and building on this data over many years we identified a significant opportunity for enhancement. Recognising the need for more granular data, we embarked on the journey to develop TRoVE, a tool designed to provide deeper insights into HCP engagements.
The Power of TRoVE: A Game-Changer for the Industry
TRoVE is the result of a nine-month collaboration with a talented group of University of Melbourne Master of Biotechnology students. This cutting-edge database enriches MA reports by identifying the specialties of over 13,000 HCPs and linking them to 18,000 locations, associated with specific centres or hospitals. With over 700,000 data points, TRoVE offers an unprecedented level of detail, empowering users to make informed decisions in areas such as therapeutic focus, competitor analysis, and market trends.
Driving Progress with Continuous Innovation
Our commitment to innovation doesn’t stop with the launch of TRoVE. We pledge to update the database biannually, in sync with new MA transparency report releases, ensuring our clients have access to the latest data and trends. This ongoing dedication to improvement keeps Commercial Eyes at the cutting edge of the industry, providing our clients with the tools they need to stay ahead.
Visualising Success: The Impact of TRoVE
TRoVE’s intuitive visualisations offer clear insights into the dynamics of HCP engagements, including:
.